Inmune Bio, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q2 2024 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Inmune Bio, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q2 2024 to Q3 2024.
- Inmune Bio, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending September 30, 2024 was $545K.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)